84
Participants
Start Date
June 14, 2021
Primary Completion Date
March 31, 2022
Study Completion Date
March 31, 2022
NO-13065
"Single ascending doses of NO-13065 in separate cohorts of subjects; each cohort consists of 6 subjects treated with NO-13065.~Single ascending dose of NO-13065 with food effect arm. Multiple ascending doses of NO-13065 for 10 or up to 28 days in separate cohorts of subjects; each cohort consists of 6 subjects treated with NO-13065."
Placebo
Two subjects per cohort will take a matched placebo.
Celerion, Lincoln
Lead Sponsor
Collaborators (1)
Celerion
INDUSTRY
Otsuka Pharmaceutical Factory, Inc.
INDUSTRY